1. Centers for Disease Control and Prevention. National Health Interview Survey. Asthma Prevalence, Health Care Use and Mortality, 2000-2001. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma/asthma.htm. Accessed April 19, 2004.
2. The health economics of asthma and rhinitis. I. Assessing the economic impact;Weiss;J Allergy Clin Immunol,2001
3. Unmet needs in the treatment of allergic asthma: potential role of novel biologic therapies;Storms;J Managed Care Pharm,2003
4. Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma;Corren;J Allergy Clin Immunol,2003
5. The Department of Defense Pharmacoeconomic Center. PEC Update. June 2003, Vol 03, Issue 6. Available at: http://www.pec.ha.osd.mil/Updates/0306web/Jun_03_Update_Page_7.htm. Accessed April 29, 2004.